Universal-Beteiligungs- und Servicegesellschaft
CPRX

Universal-Beteiligungs- und Servicegesellschaft’s Catalyst Pharmaceutical CPRX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.52M Sell
142,361
-25,402
-15% -$605K 0.01% 1024
2025
Q4 		$3.91M Buy
167,763
+38,695
+30% +$862K 0.01% 999
2025
Q3 		$2.54M Sell
129,068
-16,594
-11% -$341K ﹤0.01% 1179
2025
Q2 		$3.16M Sell
145,662
-25,174
-15% -$594K 0.01% 1014
2025
Q1 		$4.14M Sell
170,836
-8,014
-4% -$180K 0.01% 878
2024
Q4 		$3.73M Buy
+178,850
New +$3.84M 0.01% 781

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Universal-Beteiligungs- und Servicegesellschaft's CPRX Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Catalyst Pharmaceutical (CPRX) stake by 15% in Q1 2026, selling an estimated $605K and leaving 142,361 shares worth $3.52M. The position accounts for 0.01% of the portfolio, ranked #1024.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CPRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.14M in Q1 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 142,361 shares of Catalyst Pharmaceutical worth $3.52M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 25,402 Catalyst Pharmaceutical shares in Q1 2026, an estimated $605K.
  • Catalyst Pharmaceutical made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1024 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Catalyst Pharmaceutical position peaked at $4.14M in Q1 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.